BD (NYSE:BDX) today announced the introduction of the Elyra thulium fiber laser (TFL) system for treating kidney stones.

The Elyra TFL system is available in two versions, Elyra and Elyra Plus.

In early May 2026, Becton, Dickinson and Company reported higher quarterly sales of US$4.71 billion but swung to a net loss, raised its full-year adjusted earnings guidance, completed the divestiture ...

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

As the market for GLP-1 injections continues to grow, BD aims to ride that wave by providing drugmakers with its prefilled syringes. Biologic medications—including those blockbusters for diabetes and ...

The scientific-instrument company Waters will deepen its biological sciences footprint by merging with the biosciences and diagnostic solution business of Becton, Dickinson (BD). The companies value ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 second quarter, which ended March 31, 2026.

Dubai, United Arab Emirates – The Dubai branch of BD (Becton, Dickinson, and Company) (NYSE: BDX), a leading global medical technology company, is marking its presence at the region’s key healthcare ...